Filter posts

A New Addition to Pennsylvania Bio’s Leadership Team

To effectively achieve our mission as the champion and advocate of biotechnology, BIO works with …

Report Shows World's Weakest IP Environments

There is clear link between a country’s rate of economic development and the strength of …

TPP and IP: The Economic Benefits of a Pacific Trade Agreement

Ndp Analytics recently published a study on the economic benefits of intellectual property rights (IP) …

Patently Biotech’s Top Articles of 2013

Intellectual property featured prominently in 2013’s public discourse. Gene patents, patent trolls, India’s anti-patent actions, …

Universities Express Concerns About Recently Passed House “Innovation Act”

Earlier this month, the House passed the Innovation Act (H.R. 3309), which seeks to address …

VIDEO: Public Policies to Promote the Innovation Economy

What can lawmakers do to make the US more competitive globally and encourage investment in …

FDA Check-Up: Drug Development and Manufacturing Challenges

I have over 27 years of experience in the biotechnology and pharmaceutical industry. My current …

Innovation Act Passed By House

The Innovation Act (H.R. 3309), which is intended to reduce frivolous patent-related litigation, was passed …

Innovation Act Threatens Biotech Innovation

BIO has grave concerns regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee. …

TRIPs Has Delivered: Patent Agreement Increases Drug Development

The TRIPs (Trade Related Aspects of Intellectual Property) Agreement, effective in 1996, has resulted in …